Sakura Bio

Sakura Bio is an innovative biotech company transforming the future of cell therapy with effective, durable, and accessible T and NK cell treatments. Our core technology, T-Boost, enhances the potency, persistence, and resistance of reprogrammed T and NK cells against the tumor microenvironment. This modular, plug-in platform integrates seamlessly into existing workflows and supports a broad range of modalities across both solid and hematologic tumors. T-Boost has the potential to accelerate cell therapy programs by improving durability and response rates, without adding complexity or cost to manufacturing.